Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-035380)

Filing Details

Accession Number:: 0001127602-13-035380
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-20 16:31:54
Reporting Period:: 2013-12-18

Filing Date:: 2013-12-20
Accepted Time:: 2013-12-20 16:31:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242986	L David Berstein	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139	Senior Vp, Chief Ip Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-18	9,000	$0.00	225,898	No	4	M	Direct
Common Stock	Disposition	2013-12-19	4,500	$5.14	221,398	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Footnotes

Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
Represents shares sold to satisfy withholding tax requirements. Shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 21, 2012.